Log In
Print
BCIQ
Print
Print this Print this
 

Vivitrol, naltrexone

Also known as: XR-NTX (formerly Medisorb naltrexone, Vivitrex)

  Manage Alerts
Collapse Summary General Information
Company Alkermes plc
DescriptionInjectable sustained-release formulation of naltrexone in polylactide co-glycolide polymer microspheres
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsPrevent relapse to opioid dependence; Treat alcohol and opiate addiction; Treat alcohol and opiate dependence; Treat alcohol dependence; Treat opiate addiction; Treat opioid dependence; Treat opioid-using adults not physically dependent on opioids
Regulatory Designation

U.S. - Priority Review (Treat opioid dependence)

Partner

Johnson & Johnson


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today